Odaily Planet Daily reports that Swiss bank UBS Group AG disclosed in its 13F filing with the U.S. Securities and Exchange Commission (SEC) that, as of June 30, it held approximately 2.5 million shares of BlackRock’s iShares Bitcoin Trust (IBIT), with a holding value of about $90 million. By the end of 2025, UBS held approximately 549,000 shares of IBIT, valued at around $27 million; during the first half of 2026, the value of this position increased by approximately 230%. UBS’s total managed investment assets at year-end reached $7.3 trillion, with the IBIT holding accounting for less than 0.02% of its 13F-reported assets. The 13F filing discloses only certain U.S. securities managed under the company’s investment decision-making authority; the related shares primarily correspond to client assets held in wealth management, investment advisory, or asset management accounts and do not represent UBS investing $90 million of its own capital in Bitcoin. (Bitcoin.com News)
UBS Holdings in IBIT Rise 230% to $90M by Mid-2026
KuCoinFlashShare
Summary
UBS Group AG disclosed in a 13F filing that, as of June 30, 2026, it held 2.5 million shares of BlackRock’s IBIT, valued at $90 million. The position increased by 230% from $27 million in late 2025. This stake represents less than 0.02% of UBS’s $730 billion in assets under management. The 13F filing reflects client assets, not UBS’s own Bitcoin holdings. As MiCA approaches, European banks are facing heightened scrutiny regarding compliance with CFT and crypto reporting regulations.
Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information.
Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.